Aurobindo Pharma plant inspection: FDA team finds 'female mosquito' in its facility
Aurobindo Pharma facility inspection: The US FDA had issued nine observations after inspection of the drug maker's Unit 4 formulation facility near Hyderabad last month
Aurobindo Pharma had earlier informed the bourses, without providing details of the observations, that none of the observations are related to data integrity or are repetitive in nature. Image source: Company website